Electrophysiological actions of disopyramide phosphate on canine ventricular muscle and purkinje fibers.

Circulation Research
T Kus, B I Sasyniuk

Abstract

Disopyramide phosphate is a new antiarrhythmic drug that has been shown to possess significant antiarrhythmic effects in animals and man. In the present investigation, the effects of 2, 5, and 10 mug/ml of disopyramide phosphate were studied on the electrophysiological properties of canine Purkinje fibers and ventricular muscle superfused in vitro. Transmembrane action potentials were recorded from Purkinje fibers in the region of maximum action potential duration (gate), from Purkinje fibers proximal and distal to the gate, and from ventricular muscle. Disopyramide phosphate produced a concentration-dependent decrease in the slope of phase 4 diastolic depolarization of spontaneously beating Purkinje fibers. In all electrically stimulated fibers, the drug decreased the amplitude and the maximum upstroke velocity of the action potential. This depression of phase 0 characteristics was accompanied by a decrease in conduction velocity. In Purkinje fibers located at the gate, a concentration-dependent parallel shift to the right and a depression of the maximum of the membrane responsiveness curve occurred. Effects on action potential duration were variable. Repolarization was altered so that action potentials with dissimilar duratio...Continue Reading

References

Jan 1, 1975·Annual Review of Pharmacology·B I Sasyniuk, R I Ogilvie
Jan 1, 1971·Annual Review of Pharmacology·A L Bassett, B F Hoffman
Jun 1, 1974·Clinical Pharmacology and Therapeutics·G HärtelA Konttinen
Jul 1, 1973·American Heart Journal·J WittigA G Wallace
Dec 1, 1973·Journal of Pharmaceutical Sciences·B K YehB J Scherlag
Aug 1, 1974·Clinical Pharmacology and Therapeutics·L A VismaraE A Amsterdam
Jan 1, 1970·The Journal of Clinical Investigation·J T Bigger, W J Mandel
Dec 1, 1963·British Journal of Pharmacology and Chemotherapy·A SEKIYA, E M VAUGHANWILLIAMS

❮ Previous
Next ❯

Citations

Jan 1, 1988·European Journal of Clinical Pharmacology·K EndresenK Forfang
May 1, 1985·Journal of Molecular and Cellular Cardiology·A Yatani, N Akaike
Jan 1, 1983·Journal of the American College of Cardiology·B Surawicz
Apr 26, 1979·The New England Journal of Medicine·J Koch-Weser
Jan 1, 1982·Journal of Electrocardiology·S YamadaY Watanabe
Aug 9, 2003·The Journal of Pharmacy and Pharmacology·Erika HanadaTatsuji Iga
Oct 1, 1983·American Heart Journal·M R Rosen, A L Wit
Jul 1, 1981·Journal of Electrocardiology·O SarelS Rogel
Mar 1, 1983·British Journal of Pharmacology·R S de Moura, J S Lima
Nov 1, 1981·Clinical Cardiology·D García-BarretoA Hernandez-Cañero
Oct 1, 1976·American Heart Journal·P Danilo, M R Rosen
Jan 1, 1984·Annals of the New York Academy of Sciences·E M Vaughan Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.